Patrick Yeramian

Corporate Officer/Principal presso Dlx Therapeutics L L C

Patrimonio netto: 353 641 $ in data 31/05/2024

66 anni

Health Technology

Consumer Services

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Steven Gorlin	M	87	BIOVIE INC.	4 anni
Richard Berman	M	81	BIOVIE INC.	5 anni
Kari Firestone	F	68	AMYLYX PHARMACEUTICALS, INC.	1 anni
Paul R. Fonteyne	M	62	AMYLYX PHARMACEUTICALS, INC.	3 anni
Robert Hariri Gordon	M	65	BIOVIE INC.	4 anni
Sigmund Rogich	M	80	BIOVIE INC.	4 anni
Daphne Quimi	F	58	AMYLYX PHARMACEUTICALS, INC.	3 anni
Penelope Markham	M	58	BIOVIE INC.	6 anni
Jim Frates	M	56	AMYLYX PHARMACEUTICALS, INC.	3 anni
Camille Bedrosian	M	71	AMYLYX PHARMACEUTICALS, INC.	1 anni
Elizabeth Donnelly	F	-	MARKER THERAPEUTICS, INC.	9 anni
Joseph Palumbo	M	64	BIOVIE INC.	3 anni
Gina Mazzariello	F	52	AMYLYX PHARMACEUTICALS, INC.	2 anni

Mostra altro

Relazione in diverse aziende

Nome	Sesso	Età	Società collegate	Collaborazione
Michael Loiacono	M	58	MARKER THERAPEUTICS, INC.	7 anni
Frederick Wasserman	M	69	MARKER THERAPEUTICS, INC.	6 anni
John N. Bonfiglio	M	69	MARKER THERAPEUTICS, INC.	2 anni
Philip Needleman	M	-	G.D. Searle LLC	4 anni
Charles F. Fistel	M	64	Viragen, Inc. Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL.	6 anni
Mina Sooch	F	56	BIOVIE INC.	2 anni
Joshua Silverman	M	54	MARKER THERAPEUTICS, INC.	2 anni
David Laskow-Pooley	M	70	MARKER THERAPEUTICS, INC.	8 anni
Isaac Cheng	M	49	AMYLYX PHARMACEUTICALS, INC.	6 anni
John McKearn	M	70	G.D. Searle LLC	6 anni
Gary Jacob	M	77	G.D. Searle LLC	7 anni
Karen Potts	M	61	G.D. Searle LLC	4 anni
Margaret Olinger	F	60	AMYLYX PHARMACEUTICALS, INC.	4 anni
Lisa Giles	F	65	G.D. Searle LLC	4 anni
Felix von Coerper	M	-	AMYLYX PHARMACEUTICALS, INC.	-
Jeffrey Trigilio	M	40	AMYLYX PHARMACEUTICALS, INC.	-

Paese	Relazioni	% del totale
Stati Uniti	29	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni